Phase I study and preclinical efficacy evaluation of the mTOR inhibitor sirolimus plus gemcitabine in patients with advanced solid tumours. [electronic resource]
Producer: 20141017Description: 858-65 p. digitalISSN:- 1532-1827
- Adult
- Aged
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Cell Line, Tumor
- Deoxycytidine -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Evaluation, Preclinical
- Female
- Humans
- Male
- Mice, Inbred BALB C
- Mice, Nude
- Middle Aged
- Neoplasms -- drug therapy
- Sirolimus -- administration & dosage
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.